Myoclonin1 modulates the post-translational modification of microtubules
        
        
            
                    - 
                        1
                        Liège University, GIGA Neurosciences, Belgium
                    
- 
                        2
                        Maastricht University, Netherlands
                    
         Juvenile myoclonic epilepsy is one of the most common forms of generalized genetic epilepsy. Genetic studies have shown that heterozygous mutations in Myoclonin1 are responsible for 3-9% of clinical cases worldwide. This protein contains three DM10 domains of unknown function and an EF-hand domain. We have previously demonstrated that Myoclonin1 is a microtubule-associated protein involved in cell division and radial migration during neocortex development. In cells, this protein co-localized with specific structures rich in microtubules (MTs) such as the centrosome, the poles of the mitotic spindle or the motile cilia but not with cytoplasmic MTs. This suggests post-translational modifications (PTM) of MTs may be important for the interaction between Myoclonin1 and MTs.
We have co-express the different enzymes catalyzing PTM of MTs with Myoclonin1 in U2OS cell line. With one of these enzymes, we observed a strong increase in PTM in the presence of Myoclonin-1. This suggests that Myoclonin1 may interact with and modulate the activity of this enzyme. By using luciferase complementation assay and pull down experiments, we could demonstrate that it is indeed the case. Interestingly, the effect is observed even when a DM10 domain alone is co-expressed with the enzyme, suggesting for the first time a role for this domain.
In conclusion our data suggest myoclonin-1 modulates specific PTM of MTs. This is of prime importance for microtubule dynamic and notably for neuroblast precursor migration during neocortex development. This could be the mechanism that explains why pathological forms of myoclonin-1 affect brain development.
           
        
            
        
        
     
    
    
    
        
        
        
            
                
                
            
        
            Acknowledgements
        
            This work was supported by the FRS-FNRS (PDR n° T.0009.13), the Leon Frederique Fondation (to LM) and the Fonds Speciaux  of the University of Liège (FSRC-13/67).  
LM is fellow of the Fonds pour la Recherche dans l'Industrie et l'Agriculture (FRIA). BL is Research Associate at the FRS-FNRS.
        
        
        
        
        
     
    
    
    
        
            
                Keywords: 
            
                    JME, 
                
                    Myoclonin1, 
                
                    Post-translational modifications (PTMs), 
                
                    Epilepsy, 
                
                    Microtubules
        
        
            
                Conference: 
            11th National Congress of the Belgian Society for Neuroscience, Mons, Belgium, 22 May - 22 May, 2015.
        
        
            
                Presentation Type:
            Poster presentation 
        
            
                Topic:
            Neuroscience
        
        
            
                Citation:
            
                    MEDARD
                    L, 
                    GODIN
                    J, 
                    COUMANS
                    B, 
                    LAKAYE
                    B and 
                    De NIJS
                    L
            (2015). Myoclonin1 modulates the post-translational modification of microtubules. 
            
            Front. Neurosci. 
            Conference Abstract:
            11th National Congress of the Belgian Society for Neuroscience.
            
            
            doi: 10.3389/conf.fnins.2015.89.00015
            
                
                    Copyright:
                
                    The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
                They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. 
            
            
                The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
            
            
                Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
            
            
                For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. 
            
        
            
                Received:
            05 May 2015;
                Published Online:
            05 May 2015.
        
        
            *
                Correspondence:
            
            
                    Miss. Laurie MEDARD, Liège University, GIGA Neurosciences, LIEGE, 4000, Belgium, l.medard@ulg.ac.be